Indication: GBM
Title: A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
Drug: selinexor

Please visit clinicaltrials.gov for more information about this study.

Phase IPhase IIPhase III
Phase I
Phase II
Phase III